Issues: Vax Specific

Anthrax

Hepatitis B

Hib 

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Pneumococcal

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Religion

Thimerosal

 

Vaccine Info

2015 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

 

 

FirstPreviousNext Last

Dr. Halsey's presentation at the National Vaccine Advisory Committee Workshop on Thimerosal and Vaccines held in Bethesda, Maryland on August 11-12, 1999.  

Slide 4 of 26

    Slide Notes:

    During the past few years, public concern about product safety had increased. As a society, we are more concerned than ever about chemical contamination in the environment and in food; we demand that our automobiles be as safe as possible including airbags and optimal seatbelt design; and almost daily, we see recalls of toys and other products for children. These are only a part of the overall concern to make the world as safe as possible for everyone, especially children. The increased focus on drug safety - including vaccine safety - is a logical part of this overall concern.